Evidence map›Paper›PMID 33119652›Full record

ArticlePloS one2020

Evidence for co-translational misincorporation of non-canonical amino acid hydroxyproline in recombinant antibodies produced in Chinese Hamster Ovary (CHO) cell lines.

Shanta Boddapati, Jason Gilmore, Kyle Boone, John Bushey, Jonathan Ross, Brian Gfeller, William McFee, Romesh Rao, Greg Corrigan, Aaron Chen and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. How To Quantify a Genetic Firewall? A Polarity-Based Metric for Genetic Code Engineering.Chembiochem : a European journal of chemical biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Shanta BoddapatiProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.ORCID 0000-0001-9020-985X
Jason GilmoreProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.
Kyle BooneProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.
John BusheyProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.
Jonathan RossProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.
Brian GfellerProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.ORCID 0000-0003-3492-3105
William McFeeProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.
Romesh RaoProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.
Greg CorriganUpstream Manufacturing, Seattle Genetics Inc, Bothell, WA, United States of America.
Aaron ChenProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.
Howard ClarkeProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.
John Valliere-DouglassProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.
Swapnil BhargavaProcess Sciences, Seattle Genetics Inc, Bothell, WA, United States of America.
Seagen (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the advent of highly sensitive technologies such as tandem mass spectrometry and next-generation sequencing, recombinant antibodies are now routinely analyzed for the presence of low-level sequence variants including amino acid misincorporations. During mAb cell culture process development, we found that proline was replaced with the non-canonical amino acid, hydroxyproline, in the protein sequence. We investigated the relationship between proline content in the cell culture media and proline sequence variants and found that the proline concentration was inversely correlated with the amount of sequence variants detected in the protein sequence. Hydroxyproline incorporation has been previously reported in recombinant proteins produced in mammalian expression systems as a post-translational modification. Given the dependency on proline levels, the mechanism was then investigated. To address the possibility of co-translational misincorporation of hydroxyproline, we used tandem mass spectrometry to measure incorporation of stable-isotope labelled hydroxyproline added to the feed of a production bioreactor. We discovered co-translational misincorporation of labelled hydroxyproline in the recombinant antibody. These findings are significant, since they underscore the need to track non-canonical amino acid incorporation as a co-translational event in CHO cells. Understanding the mechanism of hydroxyproline incorporation is crucial in developing an appropriate control strategy during biologics production.

Indexed as

BioreactorsProtein Processing, Post-TranslationalAnimalsAntibodies, MonoclonalCHO CellsCricetulusHydroxyprolineRecombinant ProteinsAntibodies, MonoclonalHydroxyprolineRecombinant Proteins

Identifiers

PMID33119652
PMCPMC7595273
OpenAlexW3095294219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.